References
- Roumm AD, Medsger TA Jr. Cancer and systemic sclerosis. An epidemiologic study. Arthritis Rheum 1985;28:1336–40.
- Abu-Shakra M, Guillemin F, Lee P. Cancer in systemic sclerosis. Arthritis Rheum 1993;36:460–4.
- Rosenthal AK, McLaughlin JK, Gridley G, Nyren 0. Incidence of cancer among patients with systemic sclerosis. Cancer 1995;76:910–4.
- Hill CL, Nguyen AM, Roder D, Roberts-Thomson P. Risk of cancer in patients with sderoderma: a population based cohort study. Ann Rheum Dis 2003;62:728–31.
- Pearson JE, Silman AJ. Risk of cancer in patients with sclero-derma. Ann Rheum Dis 2003;62:697–9.
- Attanoos RL, Gibbs AR. "Pseudomesotheliomatous" carcinomas of the pleura: a 10-year analysis of cases from the Environmental Lung Disease Research Group, Cardiff. Histopathology 2003;43: 444–52.
- Attems JH, Lintner F. Pseudomesotheliomatous adenocarcinoma of the lung with rhabdoid features. Pathol Res Pract 2001;197:841–6.
- Braganza JM, Butler EB, Fox H, Hunter PM, Qureshi MS, Samarji W, et al. Ectopic production of salivary type amylase by a pseudomesotheliomatous carcinoma of the lung. Cancer 1978;41: 1522–5.
- Broghamer WL Jr, Collins WM, Mojsejenko IK. The cyto-histopa-thology of a pseudomesotheliomatous carcinoma of the lung. Acta Cytol 1978;22:239–42.
- Dessy E, Pietra GG. Pseudomesotheliomatous carcinoma of the lung. An immunohistochemical and ultrastructural study of three cases. Cancer 1991;68:1747–53.
- Harwood TR, Gracey DR, Yokoo H. Pseudomesotheliomatous carcinoma of the lung. A variant of peripheral lung cancer. Am J Clin Pathol 1976;65:159–67.
- Kobashi Y, Matsushima T, Irei T. Clinicopathological analysis of lung cancer resembling malignant pleural mesothelioma. Respirology 2005;10:660–5.
- Koss M, Travis W, Moran C, Hochholzer L. Pseudo-mesotheliomatous adenocarcinoma: a reappraisal. Semin Diagn Pathol 1992;9:117–23.
- Lin JI, Tseng CH, Tsung SH. Pseudomesotheliomatous carcinoma of the lung. South Med J 1980;73:655–7.
- Nishimoto Y, Ohno T, Saito K. Pseudomesotheliomatous carci-noma of the lung with histochemical and immunohistochemical study. Acta Pathol Jpn 1983;33:415–23.
- Oka K, Otani S, Yoshimura T, Hashimoto T, Tobita T, Koyamatsu S, et al. Mucin-negative pseudomesotheliomatous adenocarcinoma of the lung: report of three cases. Acta Oncol 1999;38:1119–21.
- Schreiner SR, Kirkpatrick BD, Askin FB. Pseudomesothelioma-tous adenocarcinoma of the lung in a patient with HIV infection. Chest 1998;113:839–41.
- Shah IA, Salvatore JR, Kummet T, Gani OS, Wheeler LA. Pseudomesotheliomatous carcinoma involving pleura and perito-neum: a clinicopathologic and immunohistochemical study of three cases. Ann Diagn Pathol 1999;3:148–59.
- Simonsen J. Pseudomesotheliomatous carcinoma of the lung with asbestos exposure. Am J Forensic Med Pathol 1986;7:49–51.
- Koss MN, Fleming M, Przygodzki RM, Sherrod A, Travis W, Hochholzer L. Adenocarcinoma simulating mesothelioma: a clini-copathologic and immunohistochemical study of 29 cases. Ann Diagn Pathol 1998;2:93–102.
- Ma Y, Seneviratne CK, Koss M. Idiopathic pulmonary fibrosis and malignancy. Curr Opin Pulm Med 2001;7:278–82.
- Chatterjee S, Dombi GW, Severson RK, Mayes MD. Risk of ma-lignancy in sderoderma: a population-based cohort study. Arthritis Rheum 2005;52:2415–24.
- Rothfield N, Kurtzman S, Vazques-Abad D, Charron C, Daniels L, Greenberg B. Association of anti-topoisomerase I with cancer. Arthritis Rheum 1992;35:724.
- Derk CT, Sakkas LI, Rasheed M, Artlett C, Jimenez SA. Auto-antibodies in patients with systemic sclerosis and cancer: a case-control study. J Ftheumatol 2003;30:1994–6.
- Travis WD, Colby TV, Corrin B, Shimosato Y, Brambilla E, edi-tors; in collaboration with Sobin LH and pathologists from 14 countries. Histological typing of lung and pleural tumours. World Health Organization International Histological Classification of Tumors. 3rd ed. Berlin: Springer; 1999.